Literature DB >> 9500599

Staphylokinase: a potent, uniquely fibrin-selective thrombolytic agent.

D Collen1.   

Abstract

Mesh:

Substances:

Year:  1998        PMID: 9500599     DOI: 10.1038/nm0398-279

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  25 in total

Review 1.  Thrombolytic therapy in acute myocardial infarction.

Authors:  U Priglinger; K Huber
Journal:  Drugs Aging       Date:  2000-04       Impact factor: 3.923

Review 2.  Molecular basis of thrombolytic therapy.

Authors:  H R Lijnen; D Collen
Journal:  J Nucl Cardiol       Date:  2000 Jul-Aug       Impact factor: 5.952

3.  Fibrin-targeted plasminogen activation by plasminogen activator, PadA, from Streptococcus dysgalactiae.

Authors:  Satish Singh; Timsy Bhando; Kanak L Dikshit
Journal:  Protein Sci       Date:  2014-04-05       Impact factor: 6.725

Review 4.  Pathogenesis of Staphylococcus aureus Bloodstream Infections.

Authors:  Lena Thomer; Olaf Schneewind; Dominique Missiakas
Journal:  Annu Rev Pathol       Date:  2016-02-25       Impact factor: 23.472

5.  Impact of the Pla protease substrate α2-antiplasmin on the progression of primary pneumonic plague.

Authors:  Justin L Eddy; Jay A Schroeder; Daniel L Zimbler; Lauren E Bellows; Wyndham W Lathem
Journal:  Infect Immun       Date:  2015-10-05       Impact factor: 3.441

6.  Characterization of PauB, a novel broad-spectrum plasminogen activator from Streptococcus uberis.

Authors:  Philip N Ward; James A Leigh
Journal:  J Bacteriol       Date:  2002-01       Impact factor: 3.490

7.  Expression of a staphylokinase, a thrombolytic agent in Arabidopsis thaliana.

Authors:  Aneta Wiktorek-Smagur; Katarzyna Hnatuszko-Konka; Aneta Gerszberg; Aneta Geszberg; Piotr Luchniak; Tomasz Kowalczyk; Andrzej K Kononowicz
Journal:  World J Microbiol Biotechnol       Date:  2010-10-23       Impact factor: 3.312

Review 8.  Understanding the rise of the superbug: investigation of the evolution and genomic variation of Staphylococcus aureus.

Authors:  Jodi A Lindsay; Matthew T G Holden
Journal:  Funct Integr Genomics       Date:  2006-02-02       Impact factor: 3.410

Review 9.  Tissue-type plasminogen activator as a therapeutic target in stroke.

Authors:  Iordanis Gravanis; Stella E Tsirka
Journal:  Expert Opin Ther Targets       Date:  2008-02       Impact factor: 6.902

10.  Locally activity-released bifunctional fusion protein enhances antithrombosis and alleviates bleeding risk.

Authors:  Bingxing Shi; Aiping Yu; Yuying Liu; Jingchuan Li; Jide Jin; Chunna Dong; Chutse Wu
Journal:  J Thromb Thrombolysis       Date:  2007-05-09       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.